Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
Become a Member | Sign in
Home>News>This Article

BBSRC Shows UK Commitment to European Bioinformatics Agreement

Published: Monday, September 09, 2013
Last Updated: Monday, September 09, 2013
Bookmark and Share
BBSRC has signed an agreement that will enable maximum impact of Europe's bioscience research data.

BBSRC is the first national organisation to endorse the permanent establishment of the European Life-Science Infrastructure for Biological Information (known as ELIXIR), which supports European R&D by linking biological data, analytic tools and scientific literature, and ensuring they remain freely available to scientists of all disciplines.

BBSRC has put its weight behind the initiative by signing the European Consortium Agreement (ECA), which will come into force when four further countries sign. BBSRC's backing underscores the importance of a co-ordinated, international effort to manage, upgrade and maintain Europe's vast quantities of biological data, and to establish new resources as science advances.

Professor Douglas Kell, BBSRC Chief Executive, said: "The amount of new biological data continues to increase, yet the capacity of computer storage and processing is not keeping up with the rate of increase. Without significant investment in bioinformatics services and improved skills training throughout Europe, we will rapidly lose the capacity to provide the research community with access to the treasure trove of public data in the life sciences."

"Through this agreement, BBSRC, on behalf of the UK, is showing its commitment to a successful response to the informatics opportunities that are available in order to achieve maximum scientific impact for the benefit of us all."

The ECA will form the legal basis for ELIXIR, establish an organizational structure and commit the signatories' support. The infrastructure will facilitate efficient retrieval and swift exploitation of molecular information generated by research, notably from UK-funded research breakthroughs made possible by advanced DNA sequencing technology. Importantly, it will do so in a sustainable manner.

The ELIXIR Hub is located alongside the European Bioinformatics Institute (EMBL-EBI), a world-leading centre for computational biology and long-time champion of open data in the life sciences. ELIXIR is linking centres of excellence throughout the UK and Europe, and once the ECA is in force these partnerships will be formalised. The UK's involvement in ELIXIR is supported by BBSRC, MRC and NERC.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TGAC at the Forefront of Next Generation Sequencing Capability
The Genome Analysis Centre adds two Illumina HiSeq 2500 machines to its platform suite.
Thursday, June 26, 2014
£12M for Synthetic Biology Facilities and Training
The UK Research Councils, led by the BBSRC, will award £10M to establish five centres for DNA synthesis across the UK to further develop the UK's research base in synthetic biology.
Monday, April 07, 2014
UK Establishes Three New Synthetic Biology Research Centres
Bristol, Nottingham and a Cambridge/Norwich partnership will be UK centres for synthetic biology.
Friday, January 31, 2014
BBSRC Invests in Future of Livestock Genomics
Over £1.1M of new investment has been awarded for ARK-Genomics, with a focus on the genetics and genomics of livestock species.
Monday, January 07, 2013
Collisions of Protein Machines Cause DNA Replication Derailment
Scientists have published results that will forever change the way researchers view the interplay between gene expression, DNA replication and the prevention of DNA damage.
Monday, February 28, 2011
Scientific News
Research at St Thomas’s Hospital Exploring Causative Factors of Atopic Eczema and Food Allergy in Infants
Carsten Flohr and his research group at St Thomas’s hospital, London are currently investigating the interaction between skin and gut microbiota in relation to the associated risk of atopic eczema (AE) and food allergy in infants.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Proteins Crucial to Loss of Hearing Identified
Proteins play key role in genes that help auditory hair cells grow.
New Virus Identified In Blood Supply
Scientists have discovered a new virus that can be transmitted through the blood supply.
Far-reaching Genetic Study of 1,000 UK People
300,000 gene variants from 1,000 people made publically available via F1000Research.
DNA Alterations as Among Earliest to Occur in Lung Cancer Development
Genetic footprints of precancer detectable in some blood samples.
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Genetic Sleuthing
Sabeti team applies Ebola methods to shed light on spread of Lassa fever.
Seeking “Gold Standard” Wastewater Treatments
Metagenomic analyses lend insights into how microbes break down wastewater contaminants.
Using Genetic Sequencing to Manage Cancer in Children
A team of scientists have investigated the feasibility of incorporating clinical sequencing information into the care of young cancer patients.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos